8th International Myotonic Dystrophy Consortium Meeting

简介（由申请人提供）：本申请为国际肌强直性营养不良协会（IDMC-8）第8届会议提供资助。IDMC-8将于2011年11月30日至12月3日在佛罗里达州清水镇召开。IDMC-8将汇集来自世界各地的顶尖科学家，讨论肌强直性营养不良（DM）的高影响力跨学科研究。会议的目的是促进科学讨论和促进跨学科交流。本次会议汇集了该领域领先的基础研究人员、临床医生和临床研究人员，他们代表了广泛的专业，包括：神经病学、心脏病学、麻醉学、临床试验、神经生物学、病理学、遗传学和分子生物学。他们的互动和讨论激发了研究和临床护理的新方法，并提供了发展和加强合作研究的机会。对糖尿病有特殊兴趣和专长的研究人员和临床医生将在会议期间担任科学会议的联合主席。IDMC-8的第一天将包括：注册；评估肌强直性营养不良疾病进展的结果措施卫星研讨会；主题演讲;还有一个欢迎招待会。随后三天的会议将专门用于科学会议，在会议上，研究人员和临床医生将介绍有关基础、临床和转化研究主题的经同行评审的精选摘要。科学会议每天早上8点开始，下午5点半到7点半结束。将有两个正式的海报环节。整个会议期间都会张贴海报。IDMC-8的所有会议将集中于“前沿”主题和研究，如肌强直性营养不良的疾病机制，动物和细胞模型，疾病症状的临床方面和管理，以及治疗发展。在最后一天，将有以患者为导向的会议，以促进患者、护理人员、患者倡导团体代表、临床医生和调查人员之间的讨论。这些会议将以“非专业”术语进行，以鼓励患者和研究人员之间的互动和思想交流。最后一个下午将以前几次会议的重点内容开始，随后是倡导小组的演讲，以及患者和家属的提问环节。

DESCRIPTION (provided by applicant): This application proposes funding for the 8th meeting of the International Myotonic Dystrophy Consortium (IDMC-8). IDMC-8 is scheduled to convene in Clearwater, Florida from November 30th to December 3rd, 2011. IDMC-8 will bring together top scientists from around the world to discuss high-impact, interdisciplinary research on myotonic dystrophy (DM). The objective of the conference is to promote scientific discussion and facilitate interdisciplinary exchange. This meeting brings together leading basic researchers in the field with clinicians and clinical investigators representing a broad range of specialties including: neurology, cardiology, anesthesiology, clinical trials, neurobiology, pathology, genetics and molecular biology. Their interactions and discussions stimulate new approaches to research and clinical care and provide opportunities to develop and strengthen collaborative studies. Researchers and clinicians having special interest and expertise in DM will serve as co-chairs of the scientific sessions during the meeting. The first day of IDMC-8 will include: registration; a satellite symposium on outcome measures to assess disease progression in myotonic dystrophy; keynote lectures; and a welcoming reception. The subsequent three days of the meeting will be devoted to scientific sessions in which researchers and clinicians present peer-reviewed, selected abstracts on basic, clinical and translational research topics. The scientific sessions begin at 8:00 AM and conclude between 5:30 to 7:30 PM each day. There will be two formal poster sessions. Posters will be displayed during the entire meeting. All the sessions at IDMC-8 will focus on "cutting edge" topics and research, such as, disease mechanisms of myotonic dystrophy, animal and cell models, clinical aspects and management of disease symptoms, and therapeutic development. On the final day, there will be patient-oriented sessions to promote discussion among patients, care-givers, representatives of patient advocacy groups, clinicians, and investigators. These sessions will be in "lay" terms to encourage interaction and exchanges of ideas among patients and investigators. The final afternoon will begin with highlights from the previous sessions, followed by advocacy group presentations, and a session for questions from patients and family members. PUBLIC HEALTH RELEVANCE: This application proposes funding for the 8th meeting of the International Myotonic Dystrophy Consortium (IDMC-8). Its goal is to facilitate discussions between clinical and bench researchers, and interface them with scientists and clinicians of related fields, representatives of regulatory and grant funding agencies, patient advocacy groups, patients with myotonic dystrophies and their families and caregivers. The IDMC meeting is the only conference in the world that brings together such a diverse group of attendees, including the leading experts in the field dedicated to the study, treatment and cure of myotonic dystrophy.